ロード中...
Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges
Owing to the rapid development and wide clinical application of direct acting antiviral (DAA) drugs in the treatment of hepatitis C virus (HCV) infection, the era of interferon-based therapy has almost come to an end. Cumulative studies show that DAA therapy renders high cure efficiency (>90%) an...
保存先:
| 出版年: | Int J Med Sci |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7163356/ https://ncbi.nlm.nih.gov/pubmed/32308542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.43079 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|